Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Revenue

In the fiscal year ending March 31, 2026, Jubilant Pharmova had annual revenue of 82.80B INR with 14.45% growth. Jubilant Pharmova had revenue of 22.90B in the quarter ending March 31, 2026, with 18.73% growth.

• Revenue: 82.80B
• Revenue Growth: +14.45%
• P/S Ratio: 1.82
• Revenue / Employee: 14.93M
• Employees: 5,547
• Market Cap: 150.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	82.80B	10.45B	14.45%
Mar 31, 2025	72.35B	5.32B	7.93%
Mar 31, 2024	67.03B	4.21B	6.71%
Mar 31, 2023	62.82B	1.52B	2.47%
Mar 31, 2022	61.30B	316.29M	0.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error